|Last Price$12.54||Day Change (%)0.00%|
|Open Price$12.54||Day Change ($)0.00|
|Day Range12.54–12.54||52-Week Range12.45–13.47|
As of Wed 02/28/2017 | USD
Ra Pharma Supports 10th Annual Rare Disease Day® and Joins Global Movement to Raise Awareness for Rare Diseases
Kraft-Unilever Deal Is Off, but Warren Buffett's Anomalies Live On
Dead Deal Is Clue to Buffett Strategy -- WSJ
Rockwell Automation Declares Quarterly Dividend on Common Stock
Osteopenia & Osteoporosis - Forecast in 13 Major Markets 2017-2027 - Research and Markets
Rheumatoid Arthritis - Pipeline Review, H2 2016 - Key Vendors are A&G Pharmaceutica, Amgen, GlaxoSmithKline, Merck & Novartis - Research and Markets
Research Affiliates Launches RAFI Multi-Factor and Single-Factor Index Suite
Rockwell Automation Recognized for Initiatives in Women’s Inclusion and Advancement
Most mutual fund managers do not focus on aftertax performance, but astute investors may be able to improve their aftertax returns.
©2010 Research Affiliates, LLC. The material contained in this document is for general information purposes only. It relates only to a hypothetical model of past performance of the Fundamental Index® strategy itself, and not to any asset management products based on this index. No allowance has been made for trading costs or management fees which would reduce investment performance. Actual results may differ. This material is not intended as an offer or a solicitation for the purchase and/or sale of any security or financial instrument, nor is it advice or a recommendation to enter into any transaction. This material is based on information that is considered to be reliable, but Research Affiliates® and its related entities (collectively “ RA ”) make this information available on an “as is” basis and make no warranties, express or implied regarding the accuracy of the information contained herein, for any particular purpose. RA is not responsible for any errors or omissions or for results obtained from the use of this information. Nothing contained in this material is intended to constitute legal, tax, securities, financial or investment advice, nor an opinion regarding the appropriateness of any investment. The general information contained in this material should not be acted upon without obtaining specific legal, tax or investment advice from a licensed professional. Indexes are not managed investment products, and, as such cannot be invested in directly. Returns represent back-tested performance based on rules used in the creation of the index, are not a guarantee of future performance and are not indicative of any specific investment. Research Affiliates, LLC, is an investment adviser registered under the Investment Advisors Act of 1940 with the U.S. Securities and Exchange Commission (SEC). Russell Investment Group is the source and owner of the Russell Index data contained or reflected in this material and all trademarks and copyrights related thereto. The presentation may contain confidential information and unauthorized use, disclosure, copying, dissemination, or redistribution is strictly prohibited. This is a presentation of RA . Russell Investment Group is not responsible for the formatting or configuration of this material or for any inaccuracy in RA ’s presentation thereof. The trade names Fundamental Index®, RAFI®, the RAFI logo, and the Research Affiliates corporate name and logo are registered trademarks and are the exclusive intellectual property of RA . Any use of these trade names and logos without the prior written permission of RA is expressly prohibited. RA reserves the right to take any and all necessary action to preserve all of its rights, title and interest in and to these terms and logos. Fundamental Index®, the non-capitalization method for creating and weighting of an index of securities, is patented and patent-pending proprietary intellectual property of Research Affiliates, LLC (US Patent No. 7,620,577; Patent Pending Publ. Nos. US-2005-0171884-A1, US-2006-0149645-A1, US-2007-0055598-A1, US-2008-0288416-A1, WO 2005/076812, WO 2007/078399 A2, WO 2008/118372, EPN 1733352, and HK1099110).